Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Arcadium Lithium | ALTM | 8. jan 2025 | 5.70 | +8.16 |
ArcBest | ARCB | 8. jan 2025 | 94.61 | -0.70 |
Arcellx | ACLX | 8. jan 2025 | 72.26 | -6.22 |
Arcelor Mittal ADR | MT | 8. jan 2025 | 21.82 | -0.59 |
Arch Capital F Pref | ACGLO | 8. jan 2025 | 21.64 | -0.18 |
Arch Capital G | ACGLN | 8. jan 2025 | 18.06 | -0.33 |
Arch Capital Group | ACGL | 8. jan 2025 | 92.66 | +0.44 |
Arch Resources A | ARCH | 8. jan 2025 | 140.47 | -0.78 |
Archer Aviation A | ACHR | 8. jan 2025 | 10.48 | -5.92 |
Archer Daniels Midland | ADM | 8. jan 2025 | 49.84 | +0.83 |
Archrock | AROC | 8. jan 2025 | 25.33 | -0.12 |
Arcos Dorados | ARCO | 8. jan 2025 | 7.51 | 0.00 |
Arcosa | ACA | 8. jan 2025 | 94.99 | -0.09 |
Arcturus Therapeutics | ARCT | 8. jan 2025 | 18.95 | -9.03 |
Arcus Biosciences | RCUS | 8. jan 2025 | 14.92 | -2.10 |
Arcutis Biotherapeutics | ARQT | 8. jan 2025 | 15.27 | -3.11 |
Ardagh Metal Packaging | AMBP | 8. jan 2025 | 2.73 | -0.73 |
Ardelyx | ARDX | 8. jan 2025 | 5.34 | -1.29 |
Ardent Health Partners | ARDT | 8. jan 2025 | 16.43 | +0.43 |
Ardmore Shipping | ASC | 8. jan 2025 | 12.56 | -1.64 |
Ares Acquisition II | AACT | 8. jan 2025 | 10.98 | 0.00 |
Ares Capital | ARCC | 8. jan 2025 | 22.09 | +0.09 |
Ares Commercial Real Estate | ACRE | 8. jan 2025 | 5.71 | -3.38 |
Ares Dynamic Credit Allocation Fund | ARDC | 8. jan 2025 | 15.25 | +0.33 |
Ares Management A | ARES | 8. jan 2025 | 182.30 | +2.20 |
Ares Management Pref B | ARES-B | 8. jan 2025 | 56.96 | 0.00 |
Argan | AGX | 8. jan 2025 | 155.67 | +3.69 |
argenx ADR | ARGX | 8. jan 2025 | 649.26 | +0.10 |
Argo Blockchain ADR | ARBK | 8. jan 2025 | 0.63 | -4.15 |
Argo Group International Prf A | ARGO-A | 8. jan 2025 | 24.94 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.